Literature DB >> 28892215

Living with life-prolonging chemotherapy-control and meaning-making in the tension between life and death.

K Kvåle1, O Synnes2.   

Abstract

Chemotherapy, radiotherapy, hormone therapy and immune therapy have made many cancers chronic, potential curable diseases rather than inevitably fatal, but the treatments are often both mentally and physically stressful even if the side effects varies. The right use of palliative chemotherapy is a complex issue and there are many aspects to take into consideration. The aim of the study was to gain insight into the illness narratives of cancer patients, from the day they suspected that something was wrong up to the present day where they are living with incurable cancer, undergoing life-prolonging chemotherapy. Thirteen narrators were included. They were all cancer patients on chemotherapy with the intention of prolonging life (informed by their oncologist) in an outpatient's clinic in Norway. Narrative analyse of their illness stories was applied. The main findings showed that the narrators considered their lives worth living in spite of the treatment. They seemed to take control and build a new life on "what was left after the storm," and described how they found meaning living in the tension between life and death.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  cancer patients; life-prolonging treatment; narratives

Mesh:

Year:  2017        PMID: 28892215     DOI: 10.1111/ecc.12770

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  3 in total

1.  Patients' illness narratives-From being healthy to living with incurable cancer: Encounters with doctors through the disease trajectory.

Authors:  Kirsti Kvåle; Dagny Faksvåg Haugen; Oddgeir Synnes
Journal:  Cancer Rep (Hoboken)       Date:  2019-11-19

Review 2.  Psychosocial Aspects of Living Long Term with Advanced Cancer and Ongoing Systemic Treatment: A Scoping Review.

Authors:  Evie E M Kolsteren; Esther Deuning-Smit; Alanna K Chu; Yvonne C W van der Hoeven; Judith B Prins; Winette T A van der Graaf; Carla M L van Herpen; Inge M van Oort; Sophie Lebel; Belinda Thewes; Linda Kwakkenbos; José A E Custers
Journal:  Cancers (Basel)       Date:  2022-08-11       Impact factor: 6.575

3.  Cancer patients' experiences with immune checkpoint modulators: A qualitative study.

Authors:  Kari Ala-Leppilampi; Natalie A Baker; Chris McKillop; Marcus O Butler; Lillian L Siu; Anna Spreafico; Albiruni R Abdul Razak; Anthony M Joshua; David Hogg; Philippe L Bedard; Natasha Leighl; Amit M Oza; Janet A Parsons; Aaron R Hansen
Journal:  Cancer Med       Date:  2020-03-02       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.